Researchers work to identify blood-based immune markers, including activated T cells and antibody levels, that may predict long-term survival in patients with glioblastoma.
Chibawanye Ene, MD, PhD
Chibawanye Ene, MD, PhD, is an assistant professor and physician-scientist in the Department of Neurosurgery at MD Anderson Cancer Center.
Articles by Chibawanye Ene, MD, PhD
Blood biomarkers reveal which glioblastoma patients respond to Delta-24-RGD oncolytic virus plus IFN-γ, guiding personalized dosing and survival.
